Stock listing
Frankfurt:82C NIOX Group PLC Aktie
German listing (Frankfurt) of NIOX Group PLC · home listing LSE:NIOX
Follow NIOX Group PLC into a list and get an email when it puts out news.
Share price · FWB:82C
€0.685 EUR +0.005 (+0.7%)
Close on Nov 20, 2026
- Day range
- €0.680 – €0.690 EURNov 20, 2026
- Market cap
- €288.3M EURAt the close on Nov 20, 2026 · price × 420.9M shares outstanding
- 52-week range
- €0.600 – €0.837 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €1,047 EURMedian day 0 shares · 49 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:NIOX · Home | 60.00p GBX (pence) | -1.00 (-1.6%) | 2,028,368 | 59.12p | 62.80p | 59.12p | 61.00p | Close on Nov 20, 2026 |
| Frankfurt:82C | €0.685 EUR | +0.005 (+0.7%) | — | €0.685 | €0.690 | €0.680 | €0.680 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:82C · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.740 | +0.003 | +0.4% | €0.723 | €0.747 | €0.720 | 0 | |
| €0.737 | -0.005 | -0.7% | €0.747 | €0.753 | €0.713 | 0 | |
| €0.742 | -0.004 | -0.5% | €0.750 | €0.755 | €0.741 | 0 | |
| €0.746 | -0.020 | -2.6% | €0.775 | €0.779 | €0.744 | 0 | |
| €0.766 | -0.015 | -1.9% | €0.776 | €0.776 | €0.763 | 0 | |
| €0.781 | -0.002 | -0.3% | €0.797 | €0.800 | €0.774 | 206 | |
| €0.783 | -0.004 | -0.5% | €0.780 | €0.795 | €0.772 | 1,176 | |
| €0.787 | +0.001 | +0.1% | €0.790 | €0.790 | €0.787 | 1,176 | |
| €0.786 | +0.018 | +2.3% | €0.772 | €0.790 | €0.772 | 0 | |
| €0.768 | -0.009 | -1.2% | €0.783 | €0.790 | €0.758 | 0 | |
| €0.777 | +0.005 | +0.6% | €0.778 | €0.779 | €0.777 | 0 | |
| €0.772 | +0.015 | +2.0% | €0.767 | €0.786 | €0.761 | 0 | |
| €0.757 | -0.024 | -3.1% | €0.794 | €0.794 | €0.754 | 0 | |
| €0.781 | -0.001 | -0.1% | €0.783 | €0.783 | €0.768 | 0 | |
| €0.782 | +0.005 | +0.6% | €0.787 | €0.790 | €0.768 | 0 | |
| €0.777 | +0.005 | +0.6% | €0.778 | €0.778 | €0.775 | 0 | |
| €0.772 | +0.002 | +0.3% | €0.778 | €0.778 | €0.767 | 0 | |
| €0.770 | -0.014 | -1.8% | €0.771 | €0.784 | €0.769 | 0 | |
| €0.784 | +0.011 | +1.4% | €0.787 | €0.796 | €0.776 | 0 | |
| €0.773 | +0.013 | +1.7% | €0.765 | €0.837 | €0.752 | 1,200 | |
| €0.760 | -0.003 | -0.4% | €0.777 | €0.790 | €0.759 | 12,700 | |
| €0.763 | +0.001 | +0.1% | €0.761 | €0.763 | €0.761 | 54,000 | |
| €0.762 | -0.001 | -0.1% | €0.773 | €0.776 | €0.762 | 0 | |
| €0.763 | +0.004 | +0.5% | €0.766 | €0.771 | €0.763 | 0 | |
| €0.759 | -0.001 | -0.1% | €0.759 | €0.759 | €0.759 | 0 | |
| €0.760 | +0.013 | +1.7% | €0.750 | €0.764 | €0.748 | 0 | |
| €0.747 | +0.001 | +0.1% | €0.777 | €0.796 | €0.741 | 0 | |
| €0.746 | +0.004 | +0.5% | €0.758 | €0.766 | €0.744 | 0 | |
| €0.742 | +0.011 | +1.5% | €0.742 | €0.742 | €0.742 | 0 | |
| €0.731 | +0.007 | +1.0% | €0.736 | €0.740 | €0.728 | 0 | |
| €0.724 | -0.032 | -4.2% | €0.756 | €0.763 | €0.724 | 0 | |
| €0.756 | +0.003 | +0.4% | €0.758 | €0.759 | €0.749 | 0 | |
| €0.753 | +0.001 | +0.1% | €0.760 | €0.763 | €0.751 | 0 | |
| €0.752 | +0.007 | +0.9% | €0.762 | €0.766 | €0.750 | 4,894 | |
| €0.745 | -0.011 | -1.5% | €0.750 | €0.761 | €0.738 | 0 | |
| €0.756 | +0.018 | +2.4% | €0.747 | €0.760 | €0.745 | 0 | |
| €0.738 | +0.003 | +0.4% | €0.741 | €0.755 | €0.729 | 0 | |
| €0.735 | -0.003 | -0.4% | €0.738 | €0.744 | €0.734 | 0 | |
| €0.738 | +0.006 | +0.8% | €0.738 | €0.752 | €0.737 | 0 | |
| €0.732 | -0.003 | -0.4% | €0.740 | €0.817 | €0.729 | 3,000 | |
| €0.735 | +0.011 | +1.5% | €0.731 | €0.736 | €0.726 | 0 | |
| €0.724 | -0.008 | -1.1% | €0.735 | €0.754 | €0.718 | 0 | |
| €0.732 | -0.024 | -3.2% | €0.744 | €0.748 | €0.726 | 0 | |
| €0.756 | +0.002 | +0.3% | €0.764 | €0.768 | €0.756 | 0 | |
| €0.754 | +0.003 | +0.4% | €0.759 | €0.775 | €0.749 | 0 | |
| €0.751 | -0.003 | -0.4% | €0.757 | €0.771 | €0.744 | 0 | |
| €0.754 | +0.002 | +0.3% | €0.765 | €0.768 | €0.754 | 0 | |
| €0.752 | -0.002 | -0.3% | €0.763 | €0.773 | €0.750 | 0 | |
| €0.754 | -0.005 | -0.7% | €0.769 | €0.770 | €0.725 | 0 | |
| €0.759 | -0.002 | -0.3% | €0.759 | €0.759 | €0.759 | 0 | |
| €0.761 | -0.007 | -0.9% | €0.763 | €0.775 | €0.754 | 0 | |
| €0.768 | +0.003 | +0.4% | €0.769 | €0.775 | €0.767 | 0 | |
| €0.765 | +0.014 | +1.9% | €0.754 | €0.774 | €0.751 | 0 | |
| €0.751 | -0.007 | -0.9% | €0.769 | €0.778 | €0.749 | 0 | |
| €0.758 | -0.013 | -1.7% | €0.771 | €0.773 | €0.755 | 0 | |
| €0.771 | -0.002 | -0.3% | €0.779 | €0.779 | €0.761 | 0 | |
| €0.773 | +0.016 | +2.1% | €0.773 | €0.781 | €0.739 | 0 |
- Ticker
- Frankfurt:82C
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 9, 2026
Holding(s) in Company
Latest news
Total Voting Rights
Nov 5, 2026
Closed €0.74 (+0.4%) on Nov 6, 2026
Director/PDMR Shareholding & RPT Update
Nov 4, 2026
Closed €0.742 (-0.5%) on Nov 4, 2026
Block Listing Cancellation and Interim Review
Oct 22, 2026
Closed €0.777 (+0.6%) on Oct 23, 2026
Result of Tender, Related Party Transaction & TVR
Oct 22, 2026
Closed €0.772 (+2.0%) on Oct 22, 2026
Result of General Meeting
Oct 21, 2026
Closed €0.757 (-3.1%) on Oct 21, 2026
Dividend Timetable
Apr 24, 2026
Closed €0.743 (+3.2%) on Apr 27, 2026
Director/PDMR Shareholding
Apr 21, 2026
Closed €0.644 (+2.1%) on Apr 21, 2026
Notice of 2026 Annual General Meeting
Apr 21, 2026
Closed €0.644 (+2.1%) on Apr 21, 2026
Exercise of Options, Director Dealing and TVR
Apr 17, 2026
Closed €0.631 (+0.6%) on Apr 20, 2026
NIOX Group PLC on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 19 in the last 12 months · 186 in all · newest Nov 9, 2026 · oldest 2014
Where NIOX Group PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:NIOX · Home listing | LSE | United Kingdom | GBX |
| LS Exchange:A1XFBM | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XFBM | Lang & Schwarz | Germany | EUR |
| OTC:CSSPF | OTC | United States | USD |
| Frankfurt:82C · This page | Frankfurt | Germany | EUR |
| Stuttgart:82C | Stuttgart | Germany | EUR |
| Turquoise:NIOXL | Turquoise | United Kingdom | GBX |
| Aquis:NIOXL | Aquis | United Kingdom | GBX |
Valuation
P/E 34.7× against a median of 33.0×: 5th lowest of 6 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- £227.1M GBP
- P/E
- 34.7×
- EV/sales
- 4.7×
- EV/EBITDA
- 15.3×
- Price/book
- 3.7×
- Gross margin
- 60.8%
- Operating margin
- 22.0%
- Net margin
- 14.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| NIOX Group PLC · LSE:NIOX | US$318.1M | US$297.0M | 34.7× | 4.7× | 15.3× | 3.7× | 14.4% | 0.0× | n/a |
| COLTENE Holding AG · SIX:CLTN | US$336.6M | US$376.3M | 18.9× | 1.3× | 11.4× | 3.0× | 6.2% | 0.6× | n/a |
| Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290 | US$330.8M | US$220.5M | 29.6× | 3.4× | n/a | 1.0× | 17.2% | 0.1× | n/a |
| ACRO Biomedical Co., Ltd. · TPEX:6748 | US$327.3M | US$299.5M | n/a | 258× | n/a | 10.1× | −216.1% | 0.0× | n/a |
| Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041 | US$325.9M | US$288.8M | 44.4× | 1.2× | 9.7× | 1.1× | 3.0% | 0.1× | n/a |
| Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653 | US$325.8M | US$231.2M | 34.2× | 4.8× | n/a | 2.4× | 19.9% | 0.0× | n/a |
| CapsoVision, Inc. · NASDAQ:CV | US$325.1M | US$304.1M | n/a | 21.9× | n/a | 12.3× | −210.1% | 0.0× | 0.88 |
| Nanjing Medlander Medical Technology Co. Ltd. Class A · SSE:688273 | US$315.5M | US$208.7M | 33.0× | 3.6× | n/a | 1.5× | 16.6% | 0.0× | n/a |
| Supermax Corp. Bhd. · MYX:SUPERMX | US$312.4M | US$215.6M | n/a | 1.2× | n/a | 0.3× | −20.9% | 0.1× | n/a |
| Chongqing Xishan Science and Technology Co., Ltd. Class A · SSE:688576 | US$301.5M | US$216.0M | n/a | 5.2× | n/a | 1.2× | −19.2% | 0.0× | n/a |
| Sanara MedTech Inc. · NASDAQ:SMTI | US$299.1M | US$329.0M | n/a | 2.9× | 34.4× | 39.0× | −2.7% | 6.1× | 0.49 |
| Median of the others | US$325.5M | US$260.0M | 33.0× | 3.5× | 11.4× | 2.0× | 0.2% | 0.1× | 0.69 |
Forecasts
Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 82.40 GBX · Analysts' mean
- EPS, year to Dec 2026
- 0.029 · 4 analysts
- Revenue, year to Dec 2026
- 50.48M · 5 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jonathan Emms | Chief Executive Officer with immediate effect |
| Michael Roller | Chief Financial Officer |
| Rebecca Clayton-Wherity | Company Secretary |
| James Fischer | Singer Capital Markets Nominated Adviser & Broker |
| James Todd | Singer Capital Markets Nominated Adviser & Broker |
| Patrick Weaver | Singer Capital Markets Nominated Adviser and Broker |
Board
| Director | Role |
|---|---|
| Sarah Elizabeth Duncan | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Oct 2, 2025 | +1.4% |
| Q2 2025 | Sep 30, 2025 | +0.8% |
| Quarter to Mar 31, 2025 | Apr 1, 2025 | −1.3% |
| Q2 2024 | Sep 24, 2024 | +3.6% |
| Q4 2022 | Mar 21, 2023 · Before open | −2.2% |
| Q2 2022 | Sep 14, 2022 · Before open | +5.6% |
| Q4 2021 | Mar 22, 2022 · Before open | −7.0% |
| Quarter to Jun 30, 2021 | Sep 16, 2021 · Before open | −0.7% |
| Quarter to Mar 31, 2021 | Jun 14, 2021 | −3.5% |
Financials
Annual, in GBP
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 48.7M | 41.8M | 36.8M | 31.3M | 27.9M | 23.9M | 34.6M |
| Cost of revenue | 19.1M | 11.6M | 10.3M | 9.10M | 8.90M | 7.60M | 9.10M |
| Gross profit | 29.6M | 30.2M | 26.5M | 22.2M | 19.0M | 16.3M | 25.5M |
| Research and development | 2.60M | 2.50M | 2.30M | 3.20M | 4.60M | 6.80M | 51.1M |
| Selling, general and administrative | 9.00M | 8.80M | 8.40M | 7.50M | 6.80M | 10.2M | 13.6M |
| Operating income | 10.7M | 7.70M | 4.60M | 1.80M | -4.30M | -17.3M | -63.8M |
| Depreciation and amortization | 4.10M | 4.20M | 4.40M | 4.60M | 4.90M | 9.00M | 15.2M |
| EBITDA | 14.8M | 11.9M | 9.00M | 6.40M | 600.0K | -8.30M | -48.6M |
| Interest expense | 200.0K | 200.0K | 200.0K | 100.0K | 300.0K | 300.0K | 300.0K |
| Income before tax | 11.2M | 7.80M | 4.10M | 10.5M | -2.10M | -18.4M | -27.6M |
| Income tax | 4.20M | 4.40M | -5.40M | -3.60M | -4.40M | 8.40M | -10.8M |
| Net income | 7.00M | 3.70M | 10.7M | 16.1M | 3.60M | -33.5M | -48.3M |
| Earnings per share, basic | 0.02 | 0.01 | 0.02 | 0.04 | 0.01 | -0.09 | -0.13 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19.9M | 10.9M | 19.9M | 19.4M | 12.6M | 7.40M | 27.0M |
| Receivables | 6.00M | 6.20M | 8.80M | 7.90M | 4.50M | 18.3M | 14.8M |
| Inventory | 5.00M | 4.00M | 4.80M | 4.10M | 2.70M | 4.00M | 6.50M |
| Current assets | 30.9M | 21.1M | 33.5M | 31.4M | 19.8M | 29.7M | 48.3M |
| Goodwill | 4.80M | 4.30M | 4.60M | 4.70M | 4.80M | 5.30M | 4.80M |
| Total assets | 76.2M | 68.4M | 91.5M | 98.5M | 86.4M | 103.1M | 246.8M |
| Accounts payable | 2.20M | 1.60M | 1.10M | 500.0K | 500.0K | 5.20M | 9.10M |
| Current liabilities | 8.10M | 8.10M | 7.20M | 9.20M | 10.8M | 26.7M | 41.3M |
| Long-term debt | 109.9M | ||||||
| Total debt | 1.00M | 1.50M | 1.10M | 1.00M | 1.30M | 1.60M | 111.4M |
| Total liabilities | 8.60M | 8.90M | 7.70M | 16.6M | 19.6M | 37.0M | 162.0M |
| Shareholders' equity | 73.7M | 59.5M | 83.8M | 81.9M | 66.8M | 66.1M | 84.8M |
| Shares outstanding | 426.2M | 448.2M | 449.3M | 443.0M | 435.8M | 381.9M | 373.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 15.8M | 17.2M | 11.6M | 6.70M | 1.40M | -23.9M | -25.1M |
| Capital spending | -200.0K | -1.00M | -300.0K | -100.0K | -200.0K | -500.0K | -300.0K |
| Free cash flow | 15.6M | 16.2M | 11.3M | 6.60M | 1.20M | -24.4M | -25.4M |
| Cash from investing | -1.20M | -1.00M | -300.0K | -100.0K | -200.0K | -500.0K | -9.90M |
| Cash from financing | -5.50M | -25.1M | -10.5M | -500.0K | 4.10M | 4.30M | 21.9M |
| Dividends paid | -5.00M | -4.20M | -10.5M | ||||
| Share buybacks | 0 | -21.3M | 0 | ||||
| Change in cash | 9.00M | -9.00M | 500.0K | 6.80M | 5.20M | -19.6M | -13.7M |
Cap table
Built by 6ix from NIOX Group PLC’s releases
- Common shares
- 405,273,133
- Fully diluted
- 405,273,133
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 405,273,133 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 405,273,133 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Fischer | Singer Capital Markets Nominated Adviser & Broker · Since at least Oct 22, 2026 |
| James Todd | Singer Capital Markets Nominated Adviser & Broker · Since at least Oct 1, 2025 |
| Jonathan Emms | Chief Executive Officer with immediate effect · Since at least Jan 16, 2025 |
| Michael Roller | Chief Financial Officer · Since at least Jan 16, 2025 |
| Patrick Weaver | Singer Capital Markets Nominated Adviser and Broker · Since at least Oct 22, 2026 |
| Rebecca Clayton-Wherity | Company Secretary · Since at least Apr 24, 2026 |
| Sarah Elizabeth Duncan | Director · Since at least Jan 16, 2025 |
Log in to ask 6ix AI your own questions about NIOX Group PLC.